Andrew Huberman· PhD
The state of Kentucky just recently decided to give $42 million from the opioid lawsuit settlement with Purdue pharmaceuticals to the study of ibogaine.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
The state of Kentucky just recently decided to give $42 million from the opioid lawsuit settlement with Purdue pharmaceuticals to the study of ibogaine.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the state of Kentucky recently took the $40 million settlement from the opioid thing right you've all heard about that the opioid crisis and applied that money to iboga trials